580 related articles for article (PubMed ID: 31078520)
41. MicroRNA-183 affects the development of gastric cancer by regulating autophagy via MALAT1-miR-183-SIRT1 axis and PI3K/AKT/mTOR signals.
Li H; He C; Wang X; Wang H; Nan G; Fang L
Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):3163-3171. PubMed ID: 31352788
[TBL] [Abstract][Full Text] [Related]
42. CLDN4 silencing promotes proliferation and reduces chemotherapy sensitivity of gastric cancer cells through activation of the PI3K/Akt signalling pathway.
Luo J; Wang H; Chen H; Gan G; Zheng Y
Exp Physiol; 2020 Jun; 105(6):979-988. PubMed ID: 31856376
[TBL] [Abstract][Full Text] [Related]
43. MicroRNA-34A inhibits the growth, invasion and metastasis of gastric cancer by targeting PDGFR and MET expression.
Peng Y; Guo JJ; Liu YM; Wu XL
Biosci Rep; 2014 Jun; 34(3):. PubMed ID: 24837198
[TBL] [Abstract][Full Text] [Related]
44. Inhibition of c-Myc by let-7b mimic reverses mutidrug resistance in gastric cancer cells.
Yang X; Cai H; Liang Y; Chen L; Wang X; Si R; Qu K; Jiang Z; Ma B; Miao C; Li J; Wang B; Gao P
Oncol Rep; 2015 Apr; 33(4):1723-30. PubMed ID: 25633261
[TBL] [Abstract][Full Text] [Related]
45. VPS33B interacts with NESG1 to suppress cell growth and cisplatin chemoresistance in ovarian cancer.
Ning Y; Zeng Z; Deng Y; Feng W; Huang L; Liu H; Lin J; Zhang C; Fan Y; Liu L
Cancer Sci; 2021 May; 112(5):1785-1797. PubMed ID: 33788346
[TBL] [Abstract][Full Text] [Related]
46. ATXN2-Mediated PI3K/AKT Activation Confers Gastric Cancer Chemoresistance and Attenuates CD8
Wang Q; Cao T; Zhang X; Hui J; Wang C; Zhang W; Wang P; Zhou Y; Han S
J Immunol Res; 2022; 2022():6863240. PubMed ID: 36213324
[TBL] [Abstract][Full Text] [Related]
47. MiR-181d inhibits cell proliferation and metastasis through PI3K/AKT pathway in gastric cancer.
Jiang K; Xie LF; Xiao TZ; Qiu MY; Wang WL
Eur Rev Med Pharmacol Sci; 2019 Oct; 23(20):8861-8869. PubMed ID: 31696473
[TBL] [Abstract][Full Text] [Related]
48. MiR-19a promotes epithelial-mesenchymal transition through PI3K/AKT pathway in gastric cancer.
Lu WD; Zuo Y; Xu Z; Zhang M
World J Gastroenterol; 2015 Apr; 21(15):4564-73. PubMed ID: 25914465
[TBL] [Abstract][Full Text] [Related]
49. miR-101 alleviates chemoresistance of gastric cancer cells by targeting ANXA2.
Bao J; Xu Y; Wang Q; Zhang J; Li Z; Li D; Li J
Biomed Pharmacother; 2017 Aug; 92():1030-1037. PubMed ID: 28609840
[TBL] [Abstract][Full Text] [Related]
50. MicroRNA-23a-3p influences the molecular mechanism of gastric cancer cells via CCL22/PI3K/Akt axis.
Jiang Z; Chen H; Su M; Wu L; Yu X; Liu Z
Bioengineered; 2021 Dec; 12(2):11277-11287. PubMed ID: 34874224
[TBL] [Abstract][Full Text] [Related]
51. Downregulation of microRNA-193-3p inhibits tumor proliferation migration and chemoresistance in human gastric cancer by regulating PTEN gene.
Jian B; Li Z; Xiao D; He G; Bai L; Yang Q
Tumour Biol; 2016 Jul; 37(7):8941-9. PubMed ID: 26753960
[TBL] [Abstract][Full Text] [Related]
52. Long non-coding RNA PCAT6 targets miR-204 to modulate the chemoresistance of colorectal cancer cells to 5-fluorouracil-based treatment through HMGA2 signaling.
Wu H; Zou Q; He H; Liang Y; Lei M; Zhou Q; Fan D; Shen L
Cancer Med; 2019 May; 8(5):2484-2495. PubMed ID: 30938104
[TBL] [Abstract][Full Text] [Related]
53. TCF21 inhibits proliferation and chemoresistance through the AKT pathway in human gastric cancer.
Yang Z; Jiang X; Li D; Dong Q; Zhao H; Jiang X
Gene; 2019 Jan; 682():42-49. PubMed ID: 30296564
[TBL] [Abstract][Full Text] [Related]
54. miR-494 acts as an anti-oncogene in gastric carcinoma by targeting c-myc.
He W; Li Y; Chen X; Lu L; Tang B; Wang Z; Pan Y; Cai S; He Y; Ke Z
J Gastroenterol Hepatol; 2014; 29(7):1427-34. PubMed ID: 24612089
[TBL] [Abstract][Full Text] [Related]
55. miR-3188 regulates nasopharyngeal carcinoma proliferation and chemosensitivity through a FOXO1-modulated positive feedback loop with mTOR-p-PI3K/AKT-c-JUN.
Zhao M; Luo R; Liu Y; Gao L; Fu Z; Fu Q; Luo X; Chen Y; Deng X; Liang Z; Li X; Cheng C; Liu Z; Fang W
Nat Commun; 2016 Apr; 7():11309. PubMed ID: 27095304
[TBL] [Abstract][Full Text] [Related]
56. A nuclear lncRNA Linc00839 as a Myc target to promote breast cancer chemoresistance via PI3K/AKT signaling pathway.
Chen Q; Shen H; Zhu X; Liu Y; Yang H; Chen H; Xiong S; Chi H; Xu W
Cancer Sci; 2020 Sep; 111(9):3279-3291. PubMed ID: 32619088
[TBL] [Abstract][Full Text] [Related]
57. Activation of Akt and ERK signalling pathways induced by etoposide confer chemoresistance in gastric cancer cells.
Liu SQ; Yu JP; Yu HG; Lv P; Chen HL
Dig Liver Dis; 2006 May; 38(5):310-8. PubMed ID: 16527552
[TBL] [Abstract][Full Text] [Related]
58. Long non-coding RNA BX357664 inhibits gastric cancer progression by sponging miR-183a-3p to regulate the PTEN expression and PI3K/AKT pathway.
Liang LC; Liu LQ; Liu L; Liu DL; He YR; Wan X; Zhu ZQ; Zhang BG; Liu SJ; Wu H; Hu L
Food Chem Toxicol; 2021 Apr; 150():112069. PubMed ID: 33607219
[TBL] [Abstract][Full Text] [Related]
59. MiR-484 suppressed proliferation, migration, invasion and induced apoptosis of gastric cancer via targeting CCL-18.
Liu J; Li SM
Int J Exp Pathol; 2020 Dec; 101(6):203-214. PubMed ID: 32985776
[TBL] [Abstract][Full Text] [Related]
60. Overexpression of Circular RNA ciRS-7 Abrogates the Tumor Suppressive Effect of miR-7 on Gastric Cancer via PTEN/PI3K/AKT Signaling Pathway.
Pan H; Li T; Jiang Y; Pan C; Ding Y; Huang Z; Yu H; Kong D
J Cell Biochem; 2018 Jan; 119(1):440-446. PubMed ID: 28608528
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
